A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors

NCT03057366 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors, Neoplasms, Advanced Solid

Interventions

DRUG: Pevonedistat
DRUG: [14C]-Pevonedistat
DRUG: Docetaxel
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Millennium Pharmaceuticals, Inc.